抗肿瘤新药Vismodegib研究概述
摘要
基底细胞癌（basal cell carcinoma,BCC）通常是一种始于皮肤最上层表皮的缓慢生长且无痛的皮肤癌,所发生的皮肤区域主要是定期暴露于阳光或其他紫外线辐射的部位。引起BCC的分子机制直到十几年前才揭开谜底,
出处
《药物流行病学杂志》
CAS
2013年第3期147-150,共4页
Chinese Journal of Pharmacoepidemiology
参考文献17
-
1Epstein EH, Basal cell carcinomas: attack of the hedgeheg [ J ]. Nat Rev Cancer, 2008,8 ( 10 ) :743-754.
-
2Erivedge [ EB/OL] bttp ://www. rxlist, com/erivedge-drug. htm, 2012-02 -02/2012-05 - 10.
-
3De Smaele E, Fcn'etti E, Gulino A. Vismodegib, a small-mol- ecule inhibitor of the hedgehog pathway fOr the treatment of advanced cancers [ J ]. Curr Opin lnvestig Drugs, 2010, 11 (6) :707-718.
-
4Stanton BZ, Peng LF. Small-molecule modulators of the Sonie Hedgehog signaling pathway[J] Mol Bios)~t,2010,6 (1) : 44-54.
-
5Robarge KD, Brunton SA, Castanedo GM, et al. GDC- 0449-a potent inhibitor of the hedgehog pathway [ J ]. Bioorg Med Chem. Let, t,2009,19 ( 19 ) : 5576-5581.
-
6Wong H, Theil FP, Cui Y, et al. Interplay of dissolution, solubility, and nonsink permeation determines the oral ab- sorption of the Hedgehog pathway inhibitor GDC-0449 in (togs: an investigation using pl~elinieal studies and physio- logically based pharmacokinetic modeling [ J ]. Drug Metab Dispos, 2010,38 ( 7 ) : 1029-1038.
-
7Philips GM, Chan IS, Swiderska M, et al. Hedgehog signa- ling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer[ J ]. PLoS One ,2011,6 ( 9 ) : e23943.
-
8Singh BN, Fu J, Srivastava RK,et al. Hedgehog signaling an- tag{mist GDC4)449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms [ J ]. PLoS One ,2011,6 ( 11 ) ~ e27306.
-
9Graham R, Hop C, Borin M ,et al. Single-and Multiple-Dose Intravenous and Oral Pharmacokinetics of the Hedgehog Pathway Inhibitor Vismodcgib in Healthy Female Subjects [ J]. Br J Clin Pharmacol,2012,74( 5 ) :788-796.
-
10Yue Q, Chen YH, Mulder T, et al. Absorption, distribution, metabolism, and excretion of 14C ; GDC4)449 ( vismodeg- ib) ,an orally active hedgehog pathway inhibitor, in rats and dogs: a unique metabolic pathway via pyridine ring opening [J]. Drug Metab Dispos,2011,39( 6 ) :952-965.
-
1唐春雷,解德升,冯柏年.基底细胞癌新型治疗药物vismodegib[J].中国新药杂志,2013,22(10):1111-1114. 被引量：2
-
2美国FDA批准Erivedge用于治疗基底细胞癌[J].中国新药杂志,2012,21(6):580-580.
-
3夏训明.美国FDA批准一种治疗皮肤癌新药Erivedge(vismodegib)[J].广东药学院学报,2012,28(1):46-46.
-
4孙慧芳,李艳阳,谢晓霞,黄荣清,赵砚瑾,李庶心.高效液相色谱法测定Vismodegib的含量[J].科学技术与工程,2014,22(17):165-166.
-
5赵烨.安眠药戒除记[J].解放军健康,2009(6):47-47.
-
6杨臻峥.抗癌新药Erivedge获准用于治疗基底细胞癌[J].药学进展,2012,36(2).
-
7抗肿瘤药Vismodegib[J].药学进展,2010,34(11):524-526. 被引量：1
-
8FDA批准Erivedge治疗晚期基底细胞癌[J].齐鲁药事,2012,31(3):129-129.
-
9国外新批准上市的药物新制剂新剂型（172）[J].中国制药信息,2012,28(5):16-18.
-
10李艳阳,赵砚瑾,李庶心.Hedgehog通路抑制剂vismodegib的合成[J].中国新药杂志,2013,22(17):2090-2092. 被引量：1
